title: Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons.
abstract: Parkinson's disease is characterized by a severe loss of dopaminergic neurons resulting in a range of motor deficits. The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is known to cause a similar loss of dopaminergic neurons in the human midbrain with corresponding Parkinsonian symptoms. Several animal species have also shown sensitivity to MPTP, including primates, mice, goldfish, and, most recently, zebrafish. This study demonstrates that the effect of MPTP on dopaminergic neurons in zebrafish larvae is mediated by the same pathways that have been demonstrated in mammalian species. MPTP-induced neurodegeneration was prevented by co-incubation with either the monoamine oxidase-B (MAO-B) inhibitor l-deprenyl or the dopamine transporter (DAT) inhibitor nomifensine. Furthermore, targeted inactivation of the DAT gene by antisense morpholinos also protected neurons from MPTP damage. Thus, the mechanism for MPTP-induced dopaminergic neuron toxicity in mammals is conserved in zebrafish larvae. Effects on swimming behavior and touch response that result from MPTP damage are partially ameliorated by both l-deprenyl and DAT knockdown.
authors.affiliation: Zygogen, 520 Kell Hall, 24 Peachtree Center Avenue, Atlanta, GA 30303, USA.
authors.forename: Enid T
authors.initials: ET
authors.lastname: McKinley
authors.forename: Timothy C
authors.initials: TC
authors.lastname: Baranowski
authors.forename: Delali O
authors.initials: DO
authors.lastname: Blavo
authors.forename: Candace
authors.initials: C
authors.lastname: Cato
authors.forename: Thanh N
authors.initials: TN
authors.lastname: Doan
authors.forename: Amy L
authors.initials: AL
authors.lastname: Rubinstein
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000037:antagonists & inhibitors*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000473:pathology; D004298:Dopamine / Q000502:physiology; D050483:Dopamine Plasma Membrane Transport Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics; D018390:Gene Targeting; D020267:MPTP Poisoning / Q000473:pathology / Q000517:prevention & control*; D008995:Monoamine Oxidase; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D009025:Morpholines / Q000494:pharmacology / Q000627:therapeutic use; D009410:Nerve Degeneration / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D009419:Nerve Tissue Proteins / Q000096:biosynthesis / Q000235:genetics; D009474:Neurons / Q000187:drug effects*; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D009627:Nomifensine / Q000494:pharmacology / Q000627:therapeutic use*; D020319:Oligodeoxyribonucleotides, Antisense / Q000494:pharmacology / Q000627:therapeutic use*; D012642:Selegiline / Q000494:pharmacology / Q000627:therapeutic use*; D013045:Species Specificity; D013550:Swimming; D014446:Tyrosine 3-Monooxygenase / Q000096:biosynthesis / Q000235:genetics; D015027:Zebrafish / Q000196:embryology / Q000254:growth & development
chemical_list: D050483:Dopamine Plasma Membrane Transport Proteins; D008996:Monoamine Oxidase Inhibitors; D009025:Morpholines; D009419:Nerve Tissue Proteins; D018696:Neuroprotective Agents; D020319:Oligodeoxyribonucleotides, Antisense; D009627:Nomifensine; D012642:Selegiline; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D014446:Tyrosine 3-Monooxygenase; D008995:Monoamine Oxidase; D004298:Dopamine